内科理论与实践 ›› 2023, Vol. 18 ›› Issue (05): 356-358.doi: 10.16138/j.1673-6087.2023.05.010
收稿日期:
2023-03-01
出版日期:
2023-10-30
发布日期:
2024-01-26
通讯作者:
闫卫红
E-mail:yanweihong1971@163.com
WANG Jinyu, SHANGGUAN Lijuan, SHI Ke, YAN Weihong()
Received:
2023-03-01
Online:
2023-10-30
Published:
2024-01-26
Contact:
YAN Weihong
E-mail:yanweihong1971@163.com
中图分类号:
王金于, 上官丽娟, 史可, 闫卫红. 以认知行为异常为首发症状的真性红细胞增多症合并脑梗死1例[J]. 内科理论与实践, 2023, 18(05): 356-358.
WANG Jinyu, SHANGGUAN Lijuan, SHI Ke, YAN Weihong. A case of polycythemia vera complicated with cerebral infarction with cognitive behavior abnormality as the first symptom[J]. Journal of Internal Medicine Concepts & Practice, 2023, 18(05): 356-358.
[1] | Asakura H. Thrombosis in myeloproliferative neoplasms[J]. Rinsho Ketsueki, 2018, 59(8): 1034-1041. |
[2] | 孙秉中. 真性红细胞增多症的诊断与治疗[C]. 中华医学会第十一次全国血液学学术会议论文集. 西安, 2010: 18-23. |
[3] |
Arber DA, Orazi A, Hasserjian R, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia[J]. Blood, 2016, 127(20): 2391-405.
doi: 10.1182/blood-2016-03-643544 pmid: 27069254 |
[4] |
Spivak JL. Polycythemia vera[J]. Curr Treat Options Oncol, 2018, 19(2): 12.
doi: 10.1007/s11864-018-0529-x |
[5] |
Falanga A, Marchetti M. Thrombotic disease in the myeloproliferative neoplasms[J]. Hematology Am Soc Hematol Educ Program, 2012, 2012: 571-81.
doi: 10.1182/asheducation-2012.1.571 pmid: 23233637 |
[6] |
Martin K. Risk factors for and management of MPN-associated bleeding and thrombosis[J]. Curr Hematol Malig Rep, 2017, 12(5): 389-396.
doi: 10.1007/s11899-017-0400-3 URL |
[7] |
Tefferi A, Elliott M. Thrombosis in myeloproliferative disorders: prevalence, prognostic factors, and the role of leukocytes and JAK2V617F[J]. Semin Thromb Hemost, 2007, 33(4): 313-320.
pmid: 17525888 |
[8] |
Edelmann B, Gupta N, Schnoeder TM, et al. JAK2-V617F promotes venous thrombosis through β1/β2 integrin activation[J]. J Clin Invest, 2018, 128(10): 4359-4371.
doi: 10.1172/JCI90312 pmid: 30024857 |
[9] | Wolach O, Sellar RS, Martinod K, et al. Increased neutrophil extracellular trap formation promotes thrombosis in myeloproliferative neoplasms[J]. Sci Transl Med, 2018, 10(436): eaan8292. |
[10] |
Etheridge SL, Roh ME, Cosgrove ME, et al. JAK2V617F-positive endothelial cells contribute to clotting abnormalities in myeloproliferative neoplasms[J]. Proc Natl Acad Sci U S A, 2014, 111(6): 2295-2300.
doi: 10.1073/pnas.1312148111 URL |
[11] |
Iurlo A, Cattaneo D, Bucelli C, et al. New perspectives on polycythemia vera: from diagnosis to therapy[J]. Int J Mol Sci, 2020, 21(16): 5805.
doi: 10.3390/ijms21165805 URL |
[12] |
Tefferi A, Barbui T. Polycythemia vera and essential thrombocythemia: 2021 update on diagnosis, risk-stratification and management[J]. Am J Hematol, 2020, 95(12): 1599-1613.
doi: 10.1002/ajh.v95.12 URL |
[13] |
Barbui T, Barosi G, Birgegard G, et al. Philadelphia-negative classical myeloproliferative neoplasms: critical concepts and management recommendations from European LeukemiaNet[J]. J Clin Oncol, 2011, 29(6): 761-770.
doi: 10.1200/JCO.2010.31.8436 pmid: 21205761 |
[14] | 中华医学会血液学分会白血病淋巴瘤学组. 真性红细胞增多症诊断与治疗中国专家共识(2016年版)[J]. 中华血液学杂志, 2016, 37(4): 265-268. |
[15] |
How J, Hobbs G. Management issues and controversies in low-risk patients with essential thrombocythemia and polycythemia vera[J]. Curr Hematol Malig Rep, 2021, 16(5): 473-482.
doi: 10.1007/s11899-021-00649-x |
[16] |
Marchioli R, Finazzi G, Landolfi R, et al. Vascular and neoplastic risk in a large cohort of patients with polycythemia vera[J]. J Clin Oncol, 2005, 23(10): 2224-2232.
doi: 10.1200/JCO.2005.07.062 pmid: 15710945 |
[17] |
Zwicker JI, Paranagama D, Lessen DS, et al. Hemorrhage in patients with polycythemia vera receiving aspirin with an anticoagulant: a prospective, observational study[J]. Haematologica, 2022, 107(5): 1106-1110.
doi: 10.3324/haematol.2021.279032 URL |
[18] |
Vannucchi AM. Insights into the pathogenesis and management of thrombosis in polycythemia vera and essential thrombocythemia[J]. Intern Emerg Med, 2010, 5(3): 177-184.
doi: 10.1007/s11739-009-0319-3 pmid: 19789961 |
[19] | 中华医学会神经病学分会, 中华医学会神经病学分会脑血管病学组. 中国急性脑梗死后出血转化诊治共识2019[J]. 中华神经科杂志, 2019, 52(4): 252-265. |
[1] | 李倩倩, 辛晓瑜, 汤荟冬, 吴方. 急性脑梗死住院患者脑白质疏松症的发生率及其影响因素分析[J]. 内科理论与实践, 2021, 16(04): 240-245. |
[2] | 邵建伟, 胡赟赟, 倪通天, 陈敏, 周伟君, 毛恩强, 陈尔真. 急性脑梗死患者神经功能缺损与颈动脉粥样硬化斑块关系的临床研究[J]. 内科理论与实践, 2021, 16(01): 32-36. |
[3] | 周敏慧, 谢心怡, 任汝静, 王刚. 以肢体无力为主要表现的原发性家族性脑钙化症一例报告[J]. 诊断学理论与实践, 2020, 19(1): 92-94. |
[4] | 肖卫民, 成蔚阳,. 缺血性卒中神经保护剂治疗现状和研究展望[J]. 内科理论与实践, 2019, 14(05): 282-288. |
[5] | 赵宗波, 贾传海, 刘晖. 动脉自旋标记磁共振灌注技术结合磁共振血管成像预测后循环脑梗死患者病情进展中的应用[J]. 诊断学理论与实践, 2019, 18(04): 412-417. |
[6] | 何名扬, 孟兰霞, 肖宏,. 阿尔茨海默病和帕金森病朊蛋白样传播机制的研究进展[J]. 内科理论与实践, 2018, 13(05): 312-315. |
[7] | 唐毅, 邢怡,. 性激素及其相关基因与阿尔茨海默病[J]. 内科理论与实践, 2018, 13(05): 282-287. |
[8] | 邢英琦, 陈丽敏, 陈虹秀. 经颅多普勒在脑梗死中的应用及展望[J]. 诊断学理论与实践, 2018, 17(04): 368-372. |
[9] | 任蕾, 沈宏华, 陈锐,. 阻塞性睡眠呼吸暂停低通气综合征与认知功能障碍[J]. 内科理论与实践, 2018, 13(03): 190-194. |
[10] | 孙超, 任蕾, 林桦,. 脑梗死合并不同程度记忆障碍患者的康复疗效比较[J]. 内科理论与实践, 2017, 12(04): 288-292. |
[11] | 欧茹, 李飞, 邹腾甜, 唐亚梅,. 脑梗死自发性出血性转化的影响因素分析[J]. 内科理论与实践, 2017, 12(02): 103-106. |
[12] | 王湘彬, 许晓雯, 王培军. 轻度认知功能障碍的多模态脑功能成像[J]. 诊断学理论与实践, 2017, 16(02): 131-136. |
[13] | 张世洪, 叶凯丽,. 缺血性脑损伤神经保护剂应用现状与研究进展[J]. 内科理论与实践, 2017, 12(02): 83-87. |
[14] | 慕瑾瑾, 杨康, 冯玉兰, 傅毅. 高血压性脑出血患者伴新发无症状性脑梗死的相关危险因素分析及预后的探讨[J]. 诊断学理论与实践, 2016, 15(05): 492-497. |
[15] | 买买提依明, 热西旦, 陈波, 张祥, 马卫英, 杨康, 傅毅. 染色体9p21多态性与急性非心源性脑梗死患者颈动脉斑块的易感性分析[J]. 诊断学理论与实践, 2016, 15(05): 498-502. |
阅读次数 | ||||||
全文 |
|
|||||
摘要 |
|
|||||